Concepedia

Barbara Schütt

BS

11

Publications

248

Citations

10

H-Index

1990

Active since

Affiliations

Bayer (Germany)(Current)

RAG Aktiengesellschaft (Germany)

Barbara Schütt is an author at Bayer (Germany) specializing in medicine, pharmacology, and endocrinology.

Top concepts

Publications per year

1990–2023

11

Publications

11

Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women

Barbara Schütt, Andreas Kaiser, Marcus‐Hillert Schultze‐Mosgau et al. · Human Reproduction · 2016 · 43 citations · Full text

Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer

Monika Klinkhammer‐Schalke, Brunhilde Steinger, Michael Koller et al. · European Journal of Cancer · 2020 · 40 citations

Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole and the hormone drospirenone in combination with ethinylestradiol or estradiol

Herbert Wiesinger, Matthias Berse, Stefan Klein et al. · British Journal of Clinical Pharmacology · 2015 · 32 citations · Full text

Human studies on abecarnil a new beta‐carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.

Theodora Duka, Barbara Schütt, W. Kŕause et al. · British Journal of Clinical Pharmacology · 1993 · 27 citations · Full text

Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women

Barbara Schütt, Marcus‐Hillert Schultze‐Mosgau, Corinna Draeger et al. · The Journal of Clinical Pharmacology · 2017 · 26 citations · Full text

Rows per page

1–5 of 11